Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Sinclair

Showing results (991-1000 of 1,148) with videos related to

Pageof 115
Sort By:
Journal of Neurology|August 22, 2021
Obstructive sleep apnoea in women with idiopathic intracranial hypertension: a sub-study of the idiopathic intracranial hypertension weight randomised controlled trial (IIH: WT)Andreas Yiangou, James L Mitchell, Matthew Nicholls, et al.
Headache|January 24, 2025
A randomized sequential cross-over trial evaluating five purportedly ICP-lowering drugs in idiopathic intracranial hypertensionJames L Mitchell, Hannah S Lyons, Jessica K Walker, et al.
Fluids and Barriers of the CNS|January 25, 2024
CSF hyperdynamics in rats mimicking the obesity and androgen excess characteristic of patients with idiopathic intracranial hypertensionJonathan H Wardman, Søren Norge Andreassen, Trine L Toft-Bertelsen, et al.
Ecological Applications : a Publication of the Ecological Society of America|September 2, 2022
Towards a continent-wide ecological site condition database using calibrated expert evaluationsMatthew D White, Tracey Hollings, Steve J Sinclair, et al.
Age and Ageing|June 11, 2025
Association between hypoglycaemic drug de-intensification, mortality and hospital admission in older adults with type 2 diabetes: a cohort study emulating a target trialAntoine Christiaens, Alexis Cochard, Florence Tubach, et al.
Science Translational Medicine|August 25, 2017
A glucagon-like peptide-1 receptor agonist reduces intracranial pressure in a rat model of hydrocephalusHannah F Botfield, Maria S Uldall, Connar S J Westgate, et al.
Annals of Clinical and Translational Neurology|February 17, 2025
Twelve-month change in quantitative MRI calf muscle fat fraction in CMT1A predicts clinical change over 4 yearsMatthew R B Evans, Hamza A Salhab, Christopher D J Sinclair, et al.
Diabetes & Metabolism|October 27, 2018
Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL versus glargine 100 U/mL: A patient-level meta-analysis examining older and younger adults with type 2 diabetesJ-F Yale, V R Aroda, B Charbonnel, et al.
The Journal of Nutrition, Health & Aging|February 15, 2025
Long-term frailty and physical performance transitions in older people with type-2 diabetes. The MIDFRAIL randomized clinical studyOlga Laosa, Eva Topinkova, Isabelle Bourdel-Marchasson, et al.
Environmental Toxicology and Chemistry|September 21, 2020
High Concentrations of Pharmaceuticals in a Nigerian River CatchmentOlatayo M Ogunbanwo, Paul Kay, Alistair B Boxall, et al.
Pageof 115

Showing results (991-1000 of 1,148) with videos related to

Sort By:
Pageof 115
Journal of Neurology|August 22, 2021
Obstructive sleep apnoea in women with idiopathic intracranial hypertension: a sub-study of the idiopathic intracranial hypertension weight randomised controlled trial (IIH: WT)Andreas Yiangou, James L Mitchell, Matthew Nicholls, et al.
Headache|January 24, 2025
A randomized sequential cross-over trial evaluating five purportedly ICP-lowering drugs in idiopathic intracranial hypertensionJames L Mitchell, Hannah S Lyons, Jessica K Walker, et al.
Fluids and Barriers of the CNS|January 25, 2024
CSF hyperdynamics in rats mimicking the obesity and androgen excess characteristic of patients with idiopathic intracranial hypertensionJonathan H Wardman, Søren Norge Andreassen, Trine L Toft-Bertelsen, et al.
Ecological Applications : a Publication of the Ecological Society of America|September 2, 2022
Towards a continent-wide ecological site condition database using calibrated expert evaluationsMatthew D White, Tracey Hollings, Steve J Sinclair, et al.
Age and Ageing|June 11, 2025
Association between hypoglycaemic drug de-intensification, mortality and hospital admission in older adults with type 2 diabetes: a cohort study emulating a target trialAntoine Christiaens, Alexis Cochard, Florence Tubach, et al.
Science Translational Medicine|August 25, 2017
A glucagon-like peptide-1 receptor agonist reduces intracranial pressure in a rat model of hydrocephalusHannah F Botfield, Maria S Uldall, Connar S J Westgate, et al.
Annals of Clinical and Translational Neurology|February 17, 2025
Twelve-month change in quantitative MRI calf muscle fat fraction in CMT1A predicts clinical change over 4 yearsMatthew R B Evans, Hamza A Salhab, Christopher D J Sinclair, et al.
Diabetes & Metabolism|October 27, 2018
Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL versus glargine 100 U/mL: A patient-level meta-analysis examining older and younger adults with type 2 diabetesJ-F Yale, V R Aroda, B Charbonnel, et al.
The Journal of Nutrition, Health & Aging|February 15, 2025
Long-term frailty and physical performance transitions in older people with type-2 diabetes. The MIDFRAIL randomized clinical studyOlga Laosa, Eva Topinkova, Isabelle Bourdel-Marchasson, et al.
Environmental Toxicology and Chemistry|September 21, 2020
High Concentrations of Pharmaceuticals in a Nigerian River CatchmentOlatayo M Ogunbanwo, Paul Kay, Alistair B Boxall, et al.
Pageof 115